MBX CAPITAL
MBX CAPITAL is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US and global writing $1M–$4M checks into AI, Healthcare, healthcare-tech, robotics, chemistry, clinical-medicine and environmental-tech.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- AI, Healthcare, healthcare-tech, robotics, chemistry, clinical-medicine, environmental-tech
- Check size
- $1M–$4M
- Invests in
- US-wide, global
- Actively investing
- Yes
- Founded
- 2015
- Assets under management
- $100M
- Website
- mbxcapital.com
Thesis
MBX Capital is an early-stage venture capital firm founded in 2015, focusing on 'deep health' companies that tackle the root causes of chronic diseases and environmental health issues. Their investment thesis is driven by the link between chronic diseases, environmental exposures, and industrialization. They seek visionary founders applying biology, chemistry, AI/ML, robotics, and clinical medicine to prevent and cure disease. While sector-agnostic, the core requirement is a clear 'deep health' impact. The firm typically invests in pre-seed, seed, and Series A rounds, often before a $50 million valuation. They primarily operate in the United States but are open to global opportunities. MBX Capital has committed over $100 million in capital, with an annual deployment capacity of $25 million. Typical check sizes range from $1 million to $4 million, with initial checks between $1 million and $2.5 million.
Common questions
Does MBX CAPITAL invest at the Pre-seed stage?
Yes. MBX CAPITAL lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does MBX CAPITAL write?
MBX CAPITAL writes $1M–$4M checks.
Where does MBX CAPITAL invest?
MBX CAPITAL invests in the US and global.